Citation Impact
Citing Papers
Extension of Murine Life Span by Overexpression of Catalase Targeted to Mitochondria
2005 StandoutScience
The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring
2016 StandoutScience
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein
2005 StandoutNobel
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy
2009 Standout
Clinical associations between gout and multiple sclerosis, Parkinson’s disease and motor neuron disease: record-linkage studies
2015
Plasma Urate and Parkinson's Disease in Women
2010
A study of the mechanisms involved in the neurotoxic action of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) on dopamine neurones in mouse brain
2001
Inflammation and metabolic disorders
2006 StandoutNature
Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats
2003
Liver fibrosis
2005 Standout
Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation
2000
Folate Intake and Risk of Parkinson's Disease
2004
Impaired Baroreflex Function in Mice Overexpressing Alpha-Synuclein
2013
Urate in Parkinson’s Disease: More Than a Biomarker?
2012
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Neuroprotective effects of urate are mediated by augmenting astrocytic glutathione synthesis and release
2015
The psychology and neurobiology of addiction: an incentive–sensitization view
2000
Huntington's disease
2007 Standout
Prolonged Kappa Opioid Receptor Phosphorylation Mediated by G-protein Receptor Kinase Underlies Sustained Analgesic Tolerance
2004 StandoutNobel
Impact of intermittent fasting on health and disease processes
2016
Hallmarks of aging: An expanding universe
2023 Standout
Increased affective ultrasonic communication during fear learning in adult male rats exposed to maternal immune activation
2012
Balancing Acts
2004 Standout
p53 in neuronal apoptosis
2005
Serum uric acid levels and the risk of Parkinson disease
2005
Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD
2014
Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4‐methylenedioxymethamphetamine (‘ecstasy’)‐induced dopamine release and free radical formation in the mouse striatum
2002
Molecular mechanisms of opiate and cocaine addiction
1997
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
Maternal immune activation and strain specific interactions in the development of autism-like behaviors in mice
2013
Role of brain nitric oxide in (±)3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats
1998
Diet, Urate, and Parkinson's Disease Risk in Men
2008
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Plasma Urate and Parkinson's Disease in the Atherosclerosis Risk in Communities (ARIC) Study
2009
Attenuation of methamphetamine induced dopaminergic neurotoxicity by flupirtine: microdialysis study on dopamine release and free radical generation
2003
d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxicity and hepatotoxicity
2002
Prospective study of dietary pattern and risk of Parkinson disease
2007
p53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease
2005
Gout and the risk of parkinson's disease: A cohort study
2008
Blood donations, iron stores, and risk of Parkinson's disease
2006
Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells
2013 StandoutNobel
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Prospective therapeutic applications of p53 inhibitors
2005
Low Level of Brain Dopamine D2 Receptors in Methamphetamine Abusers: Association With Metabolism in the Orbitofrontal Cortex
2001 Standout
How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?
2002
Parkinson's disease
2015 Standout
Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease
2010 Standout
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters
2005 StandoutNature
Gout
2016 Standout
α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
2005 StandoutNobel
Reduction of Nuclear Peroxisome Proliferator-Activated Receptor γ Expression in Methamphetamine-Induced Neurotoxicity and Neuroprotective Effects of Ibuprofen
2008
Cellular Reprogramming: Recent Advances in Modeling Neurological Diseases
2011
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
Glutamate and Neurotrophic Factors in Neuronal Plasticity and Disease
2008
DJ-1 Decreases Bax Expression through Repressing p53 Transcriptional Activity
2007
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Programmed Cell Senescence during Mammalian Embryonic Development
2013 Standout
Oxidants, oxidative stress and the biology of ageing
2000 StandoutNature
Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
2009
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Protection of midbrain dopaminergic neurons by the end‐product of purine metabolism uric acid: potentiation by low‐level depolarization
2009
Autophagy and Aging
2011 Standout
The tempted brain eats: Pleasure and desire circuits in obesity and eating disorders
2010
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
2006 StandoutNature
Methamphetamine toxicity and messengers of death
2009
Mitochondria in cell death: novel targets for neuroprotection and cardioprotection
2003
Gout and the risk of Parkinson’s disease in older adults: a study of U.S. Medicare data
2019
Dopamine Quinones Activate Microglia and Induce a Neurotoxic Gene Expression Profile
2006
Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA (‘ecstasy’) on the 5-HT and dopamine concentrations in mouse brain
2001
Non-motor features of Parkinson disease
2017 Standout
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Plasma Urate and Risk of Parkinson's Disease
2007
p53‐dependent neuronal cell death in a DJ‐1‐deficient zebrafish model of Parkinson's disease
2006
Role of Free Radicals in the Neurodegenerative Diseases
2001 Standout
Hepatic fibrogenesis requires sympathetic neurotransmitters
2004
The Hallmarks of Aging
2013 Standout
Methamphetamine generates peroxynitrite and produces dopaminergic neurotoxicity in mice: protective effects of peroxynitrite decomposition catalyst
1999
The Search for Antiaging Interventions: From Elixirs to Fasting Regimens
2014
Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease
2008
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Selective Inhibition of Hypoxia-Inducible Factor (HIF) Prolyl-Hydroxylase 1 Mediates Neuroprotection against Normoxic Oxidative Death via HIF- and CREB-Independent Pathways
2009 StandoutNobel
Biological fluid biomarkers in neurodegenerative parkinsonism
2009
Parkinson's Disease
2003 Standout
Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems
2005
Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps
2009
Prospective study of plasma urate and risk of Parkinson disease in men and women
2016
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
1999 StandoutScienceNobel
The Pathophysiology of Mitochondrial Cell Death
2004 StandoutScience
Gene–Diet Interactions in Brain Aging and Neurodegenerative Disorders
2003
Autocrine Tumor Necrosis Factor Alpha Links Endoplasmic Reticulum Stress to the Membrane Death Receptor Pathway through IRE1α-Mediated NF-κB Activation and Down-Regulation of TRAF2 Expression
2006
Copper Active Sites in Biology
2014 Standout
Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia
1997
Generation of an activating Zn 2+ switch in the dopamine transporter: Mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle
2002
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
2011
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
2000 StandoutNatureNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
G Protein-Coupled Receptors: Functional and Mechanistic Insights Through Altered Gene Expression
1998 StandoutNobel
Ubiquitous overexpression of CuZn superoxide dismutase does not extendlife span in mice
2000
Cardiac Sympathetic Denervation in Parkinson Disease
2000
Spermidine in health and disease
2018 StandoutScience
Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
2003 StandoutNobel
Gout and the risk of dementia: a nationwide population-based cohort study
2015
Bioinorganic Chemistry of Alzheimer’s Disease
2012
Gout
2021 Standout
Peroxynitrite Inactivation of Tyrosine Hydroxylase: Mediation by Sulfhydryl Oxidation, not Tyrosine Nitration
1999
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Meat consumption, health, and the environment
2018 StandoutScience
Neuroscience: Breaking Down Scientific Barriers to the Study of Brain and Mind
2000 StandoutScienceNobel
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
2004 StandoutScience
Sleep Dysfunction and EEG Alterations in Mice Overexpressing Alpha-Synuclein
2018
Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration
2012
Promotion of direct reprogramming by transformation-deficient Myc
2010 StandoutNobel
Neurotoxins and neurotoxic species implicated in neurodegeneration
2004
Urate: A Novel Biomarker of Parkinson‘s Disease Risk, Diagnosis and Prognosis
2010
Dietary folate, vitamin B 12 , and vitamin B 6 and the risk of Parkinson disease
2006
Works of Bruce Ladenheim being referenced
Methamphetamine-induced neurotoxicity is associated with increased striatal AP-1 DNA-binding activity in mice
1996
Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease
2001
Methamphetamine‐Induced Changes in Antioxidant Enzymes and Lipid Peroxidation in Copper/Zinc‐Superoxide Dismutase Transgenic Mice
1998
p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism
2002
Temporal profiling of methamphetamine‐induced changes in gene expression in the mouse brain: Evidence from cDNA array
2001
Analysis of methamphetamine-induced changes in the expression of integrin family members in the cortex of wild-type and c-fos knockout mice
2002
INVOLVEMENT OF OXIDATIVE AND L‐ARGININE‐NO PATHWAYS IN THE NEUROTOXICITY OF DRUGS OF ABUSE IN VITRO
1995
Transgenic superoxide dismutase mice differ in opioid-induced analgesia
1995
Prenatal Interaction of Mutant DISC1 and Immune Activation Produces Adult Psychopathology
2010
Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant α-synuclein
2012
Effects of toxic doses of methamphetamine (METH) on dopamine D1 receptors in the mouse brain
1998
Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain
2001
Ceruloplasmin deficiency results in an anxiety phenotype involving deficits in hippocampal iron, serotonin, and BDNF
2011
Methamphetamine Causes Coordinate Regulation of Src, Cas, Crk, and the Jun N-Terminal Kinase–Jun Pathway
2002
Methamphetamine-Induced Neurotoxicity Is Attenuated in Transgenic Mice with a Null Mutation for Interleukin-6
2000
Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice
1996
Distinct gene expression signatures in the striata of wild‐type and heterozygous c‐fos knockout mice following methamphetamine administration: Evidence from cDNA array analyses
2002
Role of dietary iron restriction in a mouse model of Parkinson's disease
2004
Methamphetamine Administration Causes Death of Dopaminergic Neurons in the Mouse Olfactory Bulb
2006
Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (Ecstasy)
1999
Sex-Dependent Metabolic, Neuroendocrine, and Cognitive Responses to Dietary Energy Restriction and Excess
2007
Paroxetine retards disease onset and progression in Huntingtin mutant mice
2004
Mice with Partial Deficiency of c-Jun Show Attenuation of Methamphetamine-Induced Neuronal Apoptosis
2002
Differential Regulation of Dopamine Transporter after Chronic Self-administration of Bupropion and Nomifensine
1997
Neuronal Expression of Familial Parkinson's Disease A53T α-Synuclein Causes Early Motor Impairment, Reduced Anxiety and Potential Sleep Disturbances in Mice
2013
Differential Reinforcing Effects of Cocaine and GBR-12909: Biochemical Evidence for Divergent Neuroadaptive Changes in the Mesolimbic Dopaminergic System
1996
Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis
2005
Null Mutation of c-fos Causes Exacerbation of Methamphetamine-Induced Neurotoxicity
1999
Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system.
1996
Methamphetamine induces neuronal apoptosis via cross‐talks between endoplasmic reticulum and mitochondria‐dependent death cascades
2004
Delta Opioid Peptide [d-Ala2,d-leu5]Enkephalin Blocks the Long-term Loss of Dopamine Transporters Induced by Multiple Administrations of Methamphetamine: Involvement of Opioid Receptors and Reactive Oxygen Species
1998
Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 2'-NH2-MPTP on serotonergic and noradrenergic nerve terminals.
1996